CBTRUS Statistical Report: American Brain Tumor Association & NCI Neuro-Oncology Branch Adolescent and Young Adult Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2016–2020

Neuro-Oncology, Journal Year: 2024, Volume and Issue: 26(Supplement_3), P. iii1 - iii53

Published: May 1, 2024

Abstract Recent analyses have shown that, whereas cancer survival overall has been improving, it not improved for adolescents and young adults ages 15–39 years (AYA). The clinical care of AYA with primary brain other central nervous system (CNS) tumors (BT) is complicated by the fact that histopathologies such in differ from their either children (ages 0–14 years) or older 40+ years). present report, as an update to a 2016 publication Central Brain Tumor Registry United States American Association, provides in-depth epidemiology BT first provide biomolecular marker-specific statistics prevalence histopathology both malignant non-malignant AYA. Between 2020, annual average age-specific incidence rate (AASIR) was 12.00 per 100,000 population, 12,848 newly diagnosed cases year. During same period, 1,018 deaths year were caused BT, representing mortality 0.96 population. When categorized histopathology, pituitary most common (36.6%), AASIR 4.34 Total increased age overall; when stratified sex, higher females than males at all ages. Incidence rates combined only highest non-Hispanic Indian/Alaska Native individuals, more frequent White compared racial/ethnic groups. On basis molecularly defined tumor diffuse glioma (an 1.51 100,000). Primary are second cause death overall, well specific histopathologies, vary significantly age. Accordingly, accurate statistical assessment population vital better understanding impact these on US serve reference afflicted researchers investigating new therapies, clinicians treating patients.

Language: Английский

Influence of the COVID-19 pandemic on the incidence and mortality of primary spinal tumors in the United States: A SEER analysis

European Spine Journal, Journal Year: 2025, Volume and Issue: unknown

Published: March 31, 2025

Language: Английский

Difficulties in ophthalmic symptom interpretation in a patient with COVID-19

Przeglad Epidemiologiczny, Journal Year: 2024, Volume and Issue: 78(2), P. 150 - 158

Published: July 16, 2024

In this article, we describe the case of a 70-year-old man whose diagnosis brain meningioma was hindered by SARS-CoV-2 infection. The patient, who had been vaccinated twice with AstraZeneca COVID-19 vaccine, admitted to Temporary Hospital No. 2, University (Białystok, Poland) positive PCR test result for SARS-CoV-2. patient's general condition good, but he reported significant reduction in visual acuity his left eye and headaches. A series ophthalmological examinations were conducted, they did not clarify cause decrease acuity. During hospitalization, an abnormal light reaction pupil observed, which led expansion diagnostics include imaging studies (CT MRI). Computed tomography magnetic resonance revealed extensive isointense areas anterior cranial fossa, suggesting presence meningioma. final clarification impairment resulted patient being transferred neurosurgery department surgical treatment. may mask correct interpretation other disease symptoms. Accidentally detected asymptomatic infection accelerated proper ophthalmic neurology diagnosis.

Language: Английский